HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis.

AuthorsAlmudena Matito, Cristina Blázquez-Goñi, Jose M Morgado, Iván Alvarez-Twose, Manuela Mollejo, Laura Sánchez-Muñoz, Luis Escribano
JournalAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (Ann Allergy Asthma Immunol) Vol. 111 Issue 5 Pg. 425-6 (Nov 2013) ISSN: 1534-4436 [Electronic] United States
PMID24125156 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Allergic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal, Humanized
  • Omalizumab
Topics
  • Adolescent
  • Animals
  • Anti-Allergic Agents (therapeutic use)
  • Antibodies, Anti-Idiotypic (therapeutic use)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Asthma (drug therapy, immunology)
  • Female
  • Humans
  • Mastocytosis, Cutaneous (drug therapy)
  • Omalizumab
  • Pyroglyphidae (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: